- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01716507
23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments
December 9, 2016 updated by: Wills Eye
A Prospective, Randomized Study Comparing 23-gauge and 20-gauge Pars Plana Vitrectomy for Repair of Pseudophakic Rhegmatogenous Retinal Detachments
This study is a comparison (23 gauge vs 20 gauge instrumentation) of surgical instrumentation for retinal detachment repair.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The majority of studies on PPV for PRD up to this time have used 20-gauge instrumentation.
Currently, both 23-gauge and 20-gauge instrumentation are commercially available for PPV.
No studies have reported the efficacy of 23-gauge PPV compared to 20-gauge PPV for primary pseudophakic RRD.
As a result, many retinal surgeons choose the modality based on personal preference.
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Mid Atlantic Retina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ability to provide written consent and comply with study assessments for the full duration of the study.
- Presence of retinal detachment with history of cataract surgery.
- Vision of hand motion or better.
Exclusion Criteria:
- Presence of a very large tear or type of retinal detachment usually a result of trauma.
- Prior eye surgery except for cataract surgery.
- Presence of significant scar tissue.
- Presence of retinal detachment due to hole in the macula.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 20 gauge pars plana vitrectomy
20 gauge pars plana vitrectomy for retinal detachment repair
|
Comparing 23 gauge vs 20 gauge pars plana vitrectomy.
|
Other: 23 gauge pars plana vitrectomy
23 gauge pars plana vitrectomy for retinal detachment repair
|
Comparing 23 gauge vs 20 gauge pars plana vitrectomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Assess the initial retinal reattachment rates by comparing the percentages/amount.
Time Frame: 1 Year
|
1 Year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in best-corrected visual acuity by comparing letters read.
Time Frame: 6 months
|
To determine the change in best-corrected visual acuity (BCVA) at the pre-operative visit compared to the 6 month post-operative visit
|
6 months
|
Reattachment rates with 23 gauge and 20 gauge PPV by comparing the amount.
Time Frame: 1 year
|
To determine the final retinal reattachment rates with 23-gauge and 20-gauge PPV if multiple surgeries are required.
|
1 year
|
Operating time for 23 gauge versus 20 gauge PPV (time measurement)
Time Frame: 1 day- Day of surgery
|
This will be done to determine operating times for 23-gauge versus 20-gauge PPV for primary repair of PRD.
|
1 day- Day of surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare rates of intraoperative and postoperative complications by comparing the amount and severity of these complications.
Time Frame: 1 year
|
To describe and compare rates of intraoperative and postoperative complications with 23-gauge versus 20-gauge PPV for primary repair of PRD, including but not limited to post-operative hypotony, choroidal detachment, proliferative vitreoretinopathy, and endophthalmitis.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2011
Study Registration Dates
First Submitted
October 25, 2012
First Submitted That Met QC Criteria
October 25, 2012
First Posted (Estimate)
October 29, 2012
Study Record Updates
Last Update Posted (Estimate)
December 12, 2016
Last Update Submitted That Met QC Criteria
December 9, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23VS20RD
- IRB08858 (Other Identifier: WillsEyeIRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Detachment
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Meir Medical CenterUnknownRhegmatogenous Retinal DetachmentIsrael
-
University of Campinas, BrazilCompletedRhegmatogenous Retinal Detachment
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Dar El Oyoun HospitalCairo UniversityCompletedRetinal Detachment Multiple BreaksEgypt
-
Universidade Federal do ParanáCompletedRhegmatogenous Retinal Detachment
-
Singapore National Eye CentreCompleted
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States
-
Samsung Medical CenterCompletedRhegmatogenous Retinal Detachment
Clinical Trials on Retinal Detachment repair
-
Dar El Oyoun HospitalCompleted
-
Dar El Oyoun HospitalCairo UniversityCompletedRetinal Detachment Multiple BreaksEgypt
-
Central Hospital, Nancy, FranceNot yet recruitingRetinal DetachmentFrance
-
Shanghai 10th People's HospitalUnknown
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
Ministry of Health and Population, EgyptUnknown
-
University of OxfordCompleted
-
Medical University of ViennaWithdrawnAmblyopia | Regional Blood FlowAustria
-
Nano RetinaMedPass InternationalTerminatedRetinal Degeneration | Retinitis PigmentosaBelgium, Israel, Italy
-
University of AberdeenNHS Grampian; Chief Scientist Office of the Scottish GovernmentCompletedStage 2 or 3 Full Thickness Macular HoleUnited Kingdom, Ireland